Page last updated: 2024-11-06

triethylenemelamine and Kahler Disease

triethylenemelamine has been researched along with Kahler Disease in 3 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research Excerpts

ExcerptRelevanceReference
"Urethane is the best treatment available for multiple myeloma."1.23New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MARLOW, AA1
BARTLETT, GR1
PICCINI, A1
TARGETTI, M1
MORROW, LB1
ANDERSON, RE1

Other Studies

3 other studies available for triethylenemelamine and Kahler Disease

ArticleYear
New therapy for leukemia, polycythemia, and lymphoma.
    California medicine, 1953, Volume: 78, Issue:2

    Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple

1953
[MALIGNANT HISTOPLASMOCYTOSIS (A STATISTICO-CLINICAL STUDY)].
    Il Policlinico. Sezione medica, 1963, Volume: 70

    Topics: Adrenal Cortex Hormones; Albuminuria; Alkaline Phosphatase; Androgens; Asthenia; Blood Protein Elect

1963
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
    Archives of pathology, 1965, Volume: 79

    Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu

1965